Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CHRSCHRS
31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in COHERUS ONCOLOGY INC

Yes. Geode Capital Management holds 3,685,567 shares of CHRS (Coherus Oncology), worth $5.2M, as of its Q2 2026 13F filing. It increased the position by 563,989 shares (+18.1%) from Q1 2026. Geode Capital Management has held CHRS in every 13F on record since Q4 2018, 31 quarterly filings.

Current Value

$5.2M

Current Shares

3.7M

Total Value Change

-$543,990

Total Shares Change

+3.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.7M
+18.1%
$5.2M0.0%$1.40
32
2026-Q1
Increased
3.1M
+13.7%
$5.3M0.0%$1.69
31
2025-Q4
Increased
2.7M
+0.1%
$3.9M0.0%$1.42
27
2025-Q3
Increased
2.7M
+2.4%
$4.5M0.0%$1.64
27
2025-Q2
Increased
2.7M
+0.8%
$2M0.0%$0.73
26
2025-Q1
Increased
2.7M
+2.1%
$2.1M0.0%$0.81
26
2024-Q4
Increased
2.6M
+1.3%
$3.6M0.0%$1.38
27
2024-Q3
Increased
2.6M
+7.7%
$2.7M0.0%$1.04
28
2024-Q2
Increased
2.4M
+8.1%
$4.1M0.0%$1.73
29
2024-Q1
Increased
2.2M
+5.9%
$5.3M0.0%$2.39
29
2023-Q4
Increased
2.1M
+7.0%
$6.9M0.0%$3.33
29
2023-Q3
Increased
1.9M
+36.9%
$7.3M0.0%$3.74
36
2023-Q2
Increased
1.4M
+8.6%
$6.1M0.0%$4.27
30
2023-Q1
Increased
1.3M
+3.8%
$8.9M0.0%$6.84
29
2022-Q4
Increased
1.3M
+2.5%
$10M0.0%$7.92
28
2022-Q3
Increased
1.2M
+2.7%
$11.8M0.0%$9.61
29
2022-Q2
Increased
1.2M
+2.5%
$8.7M0.0%$7.24
28
2022-Q1
Decreased
1.2M
-2.2%
$15.1M0.0%$12.91
0
2021-Q4
Decreased
1.2M
-0.3%
$19.1M0.0%$15.96
0
2021-Q3
Increased
1.2M
+1.2%
$19.2M0.0%$16.07
29
2021-Q2
Increased
1.2M
+7.7%
$16.4M0.0%$13.83
30
2021-Q1
Increased
1.1M
+11.3%
$16.1M0.0%$14.61
31
2020-Q4
Increased
987,470
+3.1%
$17.2M0.0%$17.38
29
2020-Q3
Increased
958,060
+0.3%
$17.6M0.0%$18.34
28
2020-Q2
Decreased
954,959
-1.4%
$17.1M0.0%$17.86
0
2020-Q1
Increased
968,982
+8.4%
$15.7M0.0%$16.22
31
2019-Q4
Increased
894,146
+4.4%
$16.1M0.0%$18.01
29
2019-Q3
Increased
856,569
+8.3%
$17.4M0.0%$20.26
31
2019-Q2
Increased
790,963
+13.5%
$17.5M0.0%$22.10
32
2019-Q1
Increased
696,985
+10.6%
$9.5M0.0%$13.64
31
2018-Q4
First report
630,475
-
$5.7M0.0%$9.05
0

Other major holders of CHRS: Temasek Holdings (Private) Ltd, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used